Thema: US29261A1007
EHC, US29261A1007
stock-5275746_1920.jpg - Foto: THN
Encompass Health stock: Q3 revenue rises 8.9%
Encompass Health stock followed stronger third-quarter operating results. The rehabilitation operator is expanding its hospital and bed capacity.
ad-hoc-news.de, vor 35 Minuten
EHC, US29261A1007
Raymond James sets USD 150.00 target for Encompass Health ...
Second-quarter revenue rose 9.60 percent in 2026. Encompass Health stock costs EUR 107.50 on October 20, 2026, 17.28 percent below its high.
ad-hoc-news.de, 20.10.26 18:55 Uhr
EHC, US29261A1007
Raymond James sets USD 150.00 target for Encompass Health ...
Second-quarter revenue rose 9.60 percent year over year. On NYSE, Encompass Health stock was last at USD 127.87 on October 16, 2026, down 0.08 percent.
ad-hoc-news.de, 17.10.26 18:55 Uhr
EHC, US29261A1007
UBS sets USD 155.00 target for Encompass Health stock
UBS keeps a Buy rating and sets a USD 155.00 target. Encompass Health stock costs EUR 114.50 on October 15, 2026, up 1.46 percent on the NYSE.
ad-hoc-news.de, 15.10.26 19:06 Uhr
EHC, US29261A1007
Encompass Health sets results date and EHC stock costs EUR ...
Third-quarter results follow on October 28, 2026 after the market close. Encompass Health stock costs EUR 109.50 after EUR 109.00.
ad-hoc-news.de, 08.10.26 18:32 Uhr
EHC, US29261A1007
Encompass Health stock reports 9.6 percent revenue growth ...
Encompass Health stock posted adjusted EPS of USD 1.55 in Q2 2026, beating consensus by USD 0.07. Third quarter results are scheduled for October 28, 2026.
ad-hoc-news.de, 07.10.26 00:34 Uhr
